| |
| |
|
| Insider
Information: |
Poulton Jeffrey V. |
| Relationship: |
EVP, Chief Financial O... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
27,219 |
|
|
Indirect Shares
|
57 |
|
|
| Direct
Value |
$4,081,761 |
|
|
|
Indirect Value
|
$8,548 |
|
|
| Total
Shares |
27,276 |
|
|
| Total
Value |
$4,090,309 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alnylam Pharmaceuticals Inc |
ALNY |
EVP, Chief Financial O... |
2024-03-01 |
27,219 |
2024-03-01 |
57 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Financial Officer |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,741 |
27,219 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Financial Officer |
• – – |
2024-02-28 |
4 |
S |
$154.54 |
$89,145 |
D/D |
(574) |
19,478 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Financial Officer |
• – – |
2024-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,908 |
20,052 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Financial Officer |
• – – |
2024-02-16 |
4 |
S |
$147.50 |
$149,099 |
D/D |
(1,007) |
18,144 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Financial Officer |
• – – |
2024-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,278 |
19,151 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Financial Officer |
• – – |
2023-08-04 |
4 |
S |
$184.70 |
$643,037 |
D/D |
(3,460) |
15,873 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Financial Officer |
• – – |
2023-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
7,627 |
19,333 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Financial Officer |
• – – |
2023-04-27 |
4 |
S |
$193.18 |
$190,113 |
D/D |
(977) |
11,706 |
0 |
% |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Financial Officer |
• – – |
2023-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
3,277 |
12,683 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Financial Officer |
• – – |
2022-08-04 |
4 |
D |
$189.76 |
$968,824 |
D/D |
(5,054) |
9,406 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Financial Officer |
• – – |
2022-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
11,325 |
14,460 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2021-04-20 |
4 |
D |
$131.75 |
$182,347 |
D/D |
(1,383) |
3,135 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2021-04-19 |
4 |
A |
$0.00 |
$0 |
D/D |
4,518 |
4,518 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2020-01-03 |
4 |
A |
$0.00 |
$0 |
I/I |
19 |
19 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Chief Financial Officer |
• – – |
2019-10-10 |
4 |
A |
$0.00 |
$0 |
I/I |
38 |
38 |
0 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
